Abstract
Knowledge about cancer has improved significantly in the last two decades, but there is still a considerable challenge to achieving precision medicine, which relies on validated biomarkers to better classify patients by their potential disease risk, prognosis and/or response to treatment. This study mapped the technological evolution of cancer biomarkers to understand the inventive activity, technical collaboration, advances, and technological trends in this scientific field through patent data.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
